FWM
QNTM

Focused Wealth Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Focused Wealth Management’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17
Closed -$1.02K – 1016
2023
Q4 		$1.02K Buy
+17
New +$1.2K ﹤0.01% 853

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Focused Wealth Management's QNTM Position: Q1 2024 in Review

Focused Wealth Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2024, closing a stake of 17 shares — an estimated $1.02K sold.

Focused Wealth Management first reported a position in QNTM in Q4 2023 and held it in 1 quarter. The position peaked at $1.02K in Q4 2023. 11 funds tracked by Wall St. Rank hold QNTM as of Q1 2024.

  • Focused Wealth Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 17 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2024, an estimated $1.02K.
  • Focused Wealth Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2023 and held it in 1 quarter.
  • Focused Wealth Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $1.02K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.